CYLD in Ubiquitin Signaling and Tumor Pathogenesis

Fumiyo Ikeda; Ivan Dikic

doi:10.1016/j.cell.2006.05.003

CYLD in Ubiquitin Signaling and Tumor Pathogenesis

Fumiyo Ikeda, Ivan Dikic

Research output: Contribution to journal › Short survey

21 Citations (Scopus)

Abstract

Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.

Original language	English
Pages (from-to)	643-645
Number of pages	3
Journal	Cell
Volume	125
Issue number	4
DOIs	https://doi.org/10.1016/j.cell.2006.05.003
Publication status	Published - May 19 2006
Externally published	Yes

Fingerprint

Transcription

Ubiquitin

Tumors

Skin

Genes

Enzymes

Growth

Neoplasms

Deubiquitinating Enzymes

All Science Journal Classification (ASJC) codes

Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ikeda, F., & Dikic, I. (2006). CYLD in Ubiquitin Signaling and Tumor Pathogenesis. Cell, 125(4), 643-645. https://doi.org/10.1016/j.cell.2006.05.003

CYLD in Ubiquitin Signaling and Tumor Pathogenesis. / Ikeda, Fumiyo; Dikic, Ivan.

In: Cell, Vol. 125, No. 4, 19.05.2006, p. 643-645.

Research output: Contribution to journal › Short survey

Ikeda, F & Dikic, I 2006, 'CYLD in Ubiquitin Signaling and Tumor Pathogenesis', Cell, vol. 125, no. 4, pp. 643-645. https://doi.org/10.1016/j.cell.2006.05.003

Ikeda F, Dikic I. CYLD in Ubiquitin Signaling and Tumor Pathogenesis. Cell. 2006 May 19;125(4):643-645. https://doi.org/10.1016/j.cell.2006.05.003

Ikeda, Fumiyo ; Dikic, Ivan. / CYLD in Ubiquitin Signaling and Tumor Pathogenesis. In: Cell. 2006 ; Vol. 125, No. 4. pp. 643-645.

@article{3700abc66c104e0f833e75804d198697,

title = "CYLD in Ubiquitin Signaling and Tumor Pathogenesis",

abstract = "Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.",

author = "Fumiyo Ikeda and Ivan Dikic",

year = "2006",

month = "5",

day = "19",

doi = "10.1016/j.cell.2006.05.003",

language = "English",

volume = "125",

pages = "643--645",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - CYLD in Ubiquitin Signaling and Tumor Pathogenesis

AU - Ikeda, Fumiyo

AU - Dikic, Ivan

PY - 2006/5/19

Y1 - 2006/5/19

N2 - Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.

AB - Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.

UR - http://www.scopus.com/inward/record.url?scp=33646529360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646529360&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2006.05.003

DO - 10.1016/j.cell.2006.05.003

M3 - Short survey

VL - 125

SP - 643

EP - 645

JO - Cell

JF - Cell

SN - 0092-8674

IS - 4

ER -

Access to Document

10.1016/j.cell.2006.05.003